甲基化
癌变
DNA甲基化
癌症研究
生物
分子生物学
基因
癌症
基因表达
小干扰RNA
核糖核酸
遗传学
作者
Aira Wanajo,Akane Sasaki,Hiromi Nagasaki,Shu Shimada,Takeshi Otsubo,Syuichi Owaki,Yasufumi Shimizu,Yoshinobu Eishi,Kazuyuki Kojima,Yasuaki Nakajima,Tatsuyuki Kawano,Yasuhito Yuasa,Yoshimitsu Akiyama
出处
期刊:Gastroenterology
[Elsevier BV]
日期:2008-08-01
卷期号:135 (2): 580-590.e3
被引量:72
标识
DOI:10.1053/j.gastro.2008.05.041
摘要
The calcium channel voltage-dependent alpha2delta subunit consists of 4 genes, CACNA2D1 to CACNA2D4, of which CACNA2D2 and CACNA2D3 are located on 3p21.3 and 3p21.1, respectively. Here, we examined the relation between alpha2delta subunit gene alterations and gastric carcinogenesis.The expression and methylation status of the alpha2delta subunit genes were analyzed by reverse transcription-polymerase chain reaction (RT-PCR) and methylation-specific PCR in gastric cancers (GCs). The effects of CACNA2D3 expression were examined by cell proliferation and adhesion assays, and they predicted target gene alterations.Aberrant methylation of CACNA2D1 and CACNA2D3 mostly corresponded to their expression status in GC cell lines. CACNA2D1/3 methylation was detected in 10 (12.5%) and 24 (30%) of the 80 GC cases, respectively, but no CACNA2D2 methylation was seen in 32 cases. CACNA2D3 methylation was more frequently found in diffuse type than in intestinal type (16/38 [42.1%] vs 8/42 [19.0%]; P = .025) GCs. Among the 53 patients with advanced GCs, patients with cancers showing CACNA2D3 methylation had a significantly shorter survival time than patients without this methylation (P = .003). Exogenous CACNA2D3 expression strongly inhibited cell growth and adhesion and up-regulated p21 and p27 expression in HEK-293T and NUGC4 cells. Inverse effects were seen by CACNA2D3 small interfering RNA treatment in the CACNA2D3-positive cell lines, indicating that CACNA2D3 may have tumor suppressive functions.Loss of CACNA2D3 expression through aberrant promoter hypermethylation may contribute to gastric carcinogenesis, and CACNA2D3 methylation is a useful prognostic marker for patients with advanced GC.
科研通智能强力驱动
Strongly Powered by AbleSci AI